The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients. Ungar B, Hartzell S, Lozano-Ojalvo D, Ghalili S, et al. Allergy 2022 Oct 1. doi: 10.1111/all.15540.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ungar B, Hartzell S, Lozano-Ojalvo D, Ghalili S, et al. The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients. Allergy 2022 Oct 1. doi: 10.1111/all.15540.
PMID: 36181718